Parkinson's great drug experiment /

Once diagnosed with Parkinson's disease, most patients can expect a stable and active lifestyle for up to a decade-but new drugs could lengthen that period. This program follows five volunteers in the clinical trial of MitoQ, a medicine designed to slow the ailment's progress. Viewers are...

Full description

Other Authors: Films for the Humanities & Sciences (Firm), Infobase., TVF International (Firm)
Format: Video
Language: English
Published: New York, N.Y. : Infobase, [2009], c2008.
Physical Description: 1 streaming video file (45 min.) : sd., col., digital file.
Subjects:
Table of Contents:
  • Incidence of Parkinson's Disease (0:59)
  • What Is Parkinson's? (1:09)
  • Brain Chemicals and Signals (1:23)
  • Parkinson's Disease and Movement (1:17)
  • New Drug for Parkinson's (1:11)
  • Volunteers Test Drugs (1:01)
  • Challenge of Parkinson's (1:01)
  • New Drug: New Hope (1:05)
  • Double-Blind Drug Study (1:00)
  • Drug Test Volunteer (1:02)
  • Placebo Effect (0:58)
  • Drug Test Measurements (1:11)
  • Scientific Breakthrough (1:24)
  • Blood-Brain Barrier (1:01)
  • Money for Science (1:12)
  • Drug Test Dropouts (1:10)
  • Test Invalidation (1:18)
  • Lifestyle Changes (1:55)
  • Brain Cell Death (1:48)
  • Problems with Mitochondria (1:08)
  • Antioxidants (0:58)
  • Value of Co-Enzyme Q10 (1:05)
  • Increase of Symptoms (0:59)
  • Drug Trial Drop Out (1:02)
  • Valid Test Data (1:01)
  • Comparison of Conditions (1:49)
  • Medications to Treat Symptoms (1:41)
  • Return of Symptoms (1:13)
  • Participant Speculation (1:59)
  • Test Results: Drug Failure (2:00)
  • Psychosomatic Response (1:14)
  • Disappointment in Test Results (1:22)
  • Need for Drug Testers (0:36)
  • More to Learn About Parkinson's (2:00)